We are live on ! Find out more
DZ Bank

DZ Bank Portfolio holdings

AUM $113B
1-Year Est. Return 36.92%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
+36.92%
3 Year Est. Return
+150.91%
5 Year Est. Return
+223.96%
10 Year Est. Return
AUM
$27.1B
AUM Growth
+$1.26B
Cap. Flow
-$1.1B
Cap. Flow %
-4.07%
Top 10 Hldgs %
19.33%
Holding
1,220
New
87
Increased
242
Reduced
333
Closed
370

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$162M
2
UNH icon
UnitedHealth
UNH
+$153M
3
HON icon
Honeywell
HON
+$152M
4
NTR icon
Nutrien
NTR
+$135M
5
DE icon
Deere & Co
DE
+$121M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$261M
2
CPRI icon
Capri Holdings
CPRI
+$89.4M
3
TWX
Time Warner Inc
TWX
+$88.2M
4
C icon
Citigroup
C
+$86.2M
5
GS icon
Goldman Sachs
GS
+$83.1M

Sector Composition

Rank Sector Weight
1 Financials 21.28%
2 Technology 14.24%
3 Healthcare 13.49%
4 Consumer Discretionary 11.17%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBRV
1076
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-282
Closed -$355K
MYOK
1077
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-35,876
Closed -$1.75M
IMMU
1078
DELISTED
Immunomedics Inc
IMMU
-88,867
Closed -$1.3M
LOGM
1079
DELISTED
LogMein, Inc.
LOGM
-6,700
Closed -$774K
TTPH
1080
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-6,910
Closed -$424K
BGG
1081
DELISTED
Briggs & Stratton Corp.
BGG
-477
Closed -$10K
PTLA
1082
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-26,800
Closed -$875K
PGNX
1083
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-155,431
Closed -$1.16M
STML
1084
DELISTED
Stemline Therapeutics, Inc.
STML
-24,954
Closed -$382K
RARX
1085
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-51,528
Closed -$274K
AVX
1086
DELISTED
AVX Corporation
AVX
-6,358
Closed -$105K
DERM
1087
DELISTED
Dermira, Inc.
DERM
-159,000
Closed -$1.27M
ARQL
1088
DELISTED
Arqule Inc
ARQL
-197,196
Closed -$568K
ONCE
1089
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-3,900
Closed -$260K
FWP
1090
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
-5,746
Closed -$87K
CBM
1091
DELISTED
Cambrex Corporation
CBM
-2,200
Closed -$115K
VIAB
1092
DELISTED
Viacom Inc. Class B
VIAB
-25,811
Closed -$802K
BPL
1093
DELISTED
Buckeye Partners, L.P.
BPL
-7,500
Closed -$280K
SHOS
1094
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
-16,000
Closed -$48K
ALDR
1095
DELISTED
Alder Biopharmaceuticals
ALDR
-124,900
Closed -$1.59M
SFLY
1096
DELISTED
Shutterfly, Inc.
SFLY
-802
Closed -$65K
DATA
1097
DELISTED
Tableau Software, Inc.
DATA
-114
Closed -$9K
ARRY
1098
DELISTED
Array Biopharma Inc
ARRY
-260,486
Closed -$4.25M
GM.WS.B
1099
DELISTED
General Motors Company
GM.WS.B
-200
Closed -$4K
TVPT
1100
DELISTED
Travelport Worldwide Limited
TVPT
-592
Closed -$10K

Similar funds

DZ Bank's Q2 2018 Portfolio in Review

As of Q2 2018, DZ Bank held 1,220 positions worth $27.1B, up 4.9% from $25.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

DZ Bank withdrew a net $1.1B in Q2 2018, closing 370 positions and reducing 333 holdings. Its most notable exit was Time Warner Inc, an estimated $88.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, DZ Bank opened a new position in OAKTREE CAPITAL GROUP, LLC worth $17.4M.

  • DZ Bank's largest Q2 2018 buy was OAKTREE CAPITAL GROUP, LLC: 428,064 shares worth $17.4M.
  • DZ Bank added most to Berkshire Hathaway Class A in Q2 2018, an estimated $162M increase.
  • DZ Bank's biggest Q2 2018 reduction was 3M, cutting an estimated $261M.
  • DZ Bank fully exited Time Warner Inc in Q2 2018, selling an estimated $88.2M.
  • DZ Bank's ten largest holdings make up 19% of its $27.1B portfolio in Q2 2018.
  • DZ Bank opened 87 new positions and closed 370 in Q2 2018.
  • DZ Bank's portfolio value rose 4.9% quarter-over-quarter to $27.1B.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.